These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19406270)

  • 1. Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure.
    Tang WH; Katz R; Brennan ML; Aviles RJ; Tracy RP; Psaty BM; Hazen SL
    Am J Cardiol; 2009 May; 103(9):1269-74. PubMed ID: 19406270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
    Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
    J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
    Tang WH; Wu Y; Nicholls SJ; Hazen SL
    Clin Chem; 2011 Jan; 57(1):33-9. PubMed ID: 21059827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis.
    Kolodziej AR; Abo-Aly M; Elsawalhy E; Campbell C; Ziada KM; Abdel-Latif A
    Mediators Inflamm; 2019; 2019():2872607. PubMed ID: 31341419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.
    Wong ND; Gransar H; Narula J; Shaw L; Moon JH; Miranda-Peats R; Rozanski A; Hayes SW; Thomson LE; Friedman JD; Berman DS
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1093-9. PubMed ID: 19761988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin as a predictive marker of incident heart failure.
    Schill F; Timpka S; Nilsson PM; Melander O; Enhörning S
    ESC Heart Fail; 2021 Aug; 8(4):3180-3188. PubMed ID: 34056865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C concentration as a predictor of systolic and diastolic heart failure.
    Moran A; Katz R; Smith NL; Fried LF; Sarnak MJ; Seliger SL; Psaty B; Siscovick DS; Gottdiener JS; Shlipak MG
    J Card Fail; 2008 Feb; 14(1):19-26. PubMed ID: 18226769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure.
    Tang WH; Tong W; Troughton RW; Martin MG; Shrestha K; Borowski A; Jasper S; Hazen SL; Klein AL
    J Am Coll Cardiol; 2007 Jun; 49(24):2364-70. PubMed ID: 17572253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Agarwala A; Pokharel Y; Saeed A; Sun W; Virani SS; Nambi V; Ndumele C; Shahar E; Heiss G; Boerwinkle E; Konety S; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2017 Jul; 262():131-137. PubMed ID: 28554015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
    Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma myeloperoxidase levels in patients with chronic heart failure.
    Tang WH; Brennan ML; Philip K; Tong W; Mann S; Van Lente F; Hazen SL
    Am J Cardiol; 2006 Sep; 98(6):796-9. PubMed ID: 16950188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
    Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL
    Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study).
    Lyngbakken MN; Røsjø H; Holmen OL; Nygård S; Dalen H; Hveem K; Omland T
    Am J Cardiol; 2016 Sep; 118(6):816-821. PubMed ID: 27453509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
    Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
    J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.
    Scharnagl H; Kleber ME; Genser B; Kickmaier S; Renner W; Weihrauch G; Grammer T; Rossmann C; Winkelmann BR; Boehm BO; Sattler W; März W; Malle E
    Int J Cardiol; 2014 Jun; 174(1):96-105. PubMed ID: 24746542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study.
    Januzzi JL; van Kimmenade RRJ; Liu Y; Hu X; Browne A; Plutzky J; Tsimikas S; Blankstein R; Natarajan P
    J Am Heart Assoc; 2024 Jun; 13(12):e034774. PubMed ID: 38860394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
    Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
    BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a combination of systolic function by left ventricular ejection fraction and diastolic function by E/E' to predict prognosis in patients with heart failure.
    Hirata K; Hyodo E; Hozumi T; Kita R; Hirose M; Sakanoue Y; Nishida Y; Kawarabayashi T; Yoshiyama M; Yoshikawa J; Akasaka T
    Am J Cardiol; 2009 May; 103(9):1275-9. PubMed ID: 19406271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.